PT Kalbe Farma Tbk. (IDX: KLBF)

Market Cap	57.22T
Revenue (ttm)	32.13T
Net Income (ttm)	3.08T
Shares Out	46.15B
EPS (ttm)	66.79
PE Ratio	18.56
Forward PE	17.10
Dividend	31.00 (2.54%)
Ex-Dividend Date	May 29, 2024

Volume	39,341,900
Average Volume	33,214,355
Open	1,225.00
Previous Close	1,220.00
Day's Range	1,220.00 - 1,245.00
52-Week Range	1,210.00 - 1,795.00
Beta	0.24
RSI	35.97
Earnings Date	Feb 14, 2025

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the comp...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1966
• Employees: 13,108
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: KLBF

Financial Performance

In 2023, PT Kalbe Farma Tbk.'s revenue was 30.45 trillion, an increase of 5.24% compared to the previous year's 28.93 trillion. Earnings were 2.77 trillion, a decrease of -18.20%.